Abstract

Purpose To investigate whether quantitative radiomics features extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) could be used to differentiate triple-negative breast cancer (TNBC) and nontriple-negative breast cancer (non-TNBC). Materials and Methods This retrospective study included DCE-MRI images of 81 breast cancer patients (44 TNBC and 37 non-TNBC) from August 2018 to October 2019. The MR scans were achieved at a 1.5 T MR scanner. For each patient, the largest tumor mass was selected to analyze. Three-dimensional (3D) images of the regions of interest (ROIs) were automatically segmented on the third DCE phase by a deep learning segmentation model; then, the ROIs were checked and revised by 2 radiologists. DCE-MRI radiomics features were extracted from the 3D tumor volume. The patients were randomly divided into training (N = 57) and test (N = 24) cohorts. The machine learning classifier was built in the training dataset, and 5-fold cross-validation was performed on the training cohort to train and validate. The data of the test cohort were used to investigate the predictive power of the radiomics model in predicting TNBC and non-TNBC. The performance of the model was evaluated by the area under receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. Results The radiomics model based on 15 features got the best performance. The AUC achieved 0.741 for the cross-validation, and 0.867 for the independent testing cohort. Conclusion The radiomics model based on automatic image segmentation of DCE-MRI can be used to distinguish TNBC and non-TNBC.

Highlights

  • Breast cancer is a heterogeneous disease with different clinical behavior, subtypes, and treatment responses [1, 2]

  • The purpose of this study was to investigate whether radiomics models based on automatic image segmentation of dynamic contrast-enhanced magnetic resonance imaging (DCE-Magnetic resonance imaging (MRI)) can predict Triple-negative breast cancer (TNBC) in a population of Chinese women

  • We found that the deep learning segmentation is feasible and time-saving to perform fully automatic segmentation for the breast tumor on dynamic contrast-enhanced (DCE)-MRI images

Read more

Summary

Introduction

Breast cancer is a heterogeneous disease with different clinical behavior, subtypes, and treatment responses [1, 2]. Triple-negative breast cancer (TNBC) is a particular type of breast cancer defined by the absence of estrogen and progesterone receptor expression as well as the absence of ERBB2 amplification, which accounts for 15% to 20% of breast cancers [5]. It is more aggressive and has a low survival rate and lack of effective targeted therapy. If we can accurately distinguish triple-negative and nontriple-negative breast cancer, it will help our clinical decision-making

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call